Upcoming
Expected 10-Q filing date
Date derived from this company’s past SEC EDGAR filing cadence.
Accession 0001551152-26-000026Public company research · SEC EDGAR
ABBV
U.S. listed
AbbVie Inc.
SEC CIK0001551152
Filing records and catalyst timing are sourced from the SEC EDGAR company directory and primary documents.
By ticker
Catalysts and filing highlights
Upcoming timing and recent SEC filings with validated cached summaries for this ticker.
Upcoming
Expected or scheduled dates derived from SEC EDGAR records.
Recent filings
Recent filings with a citation-validated cached summary.
Recent
Recent 8-K filing
AbbVie Incorporated expanded its Board of Directors from twelve to thirteen members. Dr. John M. Carethers was appointed as a Class II director and joined the Public Policy and Sustainability Committee.
Accession 0001104659-26-116227Recent
Recent 8-K filing
AbbVie Incorporated reported acquired IPR&D and milestones expense of $216 million for the third quarter of 2026. This expense impacted both GAAP and adjusted non-GAAP diluted earnings per share by $0.11.
Accession 0001551152-26-000030Primary evidence
Recent SEC filings
The latest approved-form filings, linked directly to their SEC EDGAR documents.
Form 8-K
Accession 0001104659-26-116227Direct EDGAR source
Form 8-K
Accession 0001551152-26-000030Direct EDGAR source
Form 4
Accession 0001997505-26-000010Direct EDGAR source
Form 4
Accession 0001171780-26-000014Direct EDGAR source
Form 8-K
Accession 0001104659-26-104940Direct EDGAR source
Form 4
Accession 0001762951-26-000006Direct EDGAR source
Form 8-K
Accession 0001104659-26-098367Direct EDGAR source
Ownership ledger
Recent 13D / 13G disclosures
Source-linked beneficial ownership facts from stored SEC EDGAR primary documents. Schedule 13D is shown as activist and Schedule 13G as passive solely by filing form.
No stored 13D or 13G disclosures.
No validated ownership disclosure is currently available for this ticker.
Continue researching
Related tickers
Industry peers first, then other actively tracked companies.